Table 1.
Summary of inter-assay precision from different ADA assay formats.
| Direct assay with protein A/G |
Direct assay with species-specific antibodies |
Bridging assay for preclinical studies |
Bridging assay for clinical studies |
ACE assay |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PCs and NC | Conc. (ng/mL) | %CV | Conc. (ng/mL) | %CV | Conc. (ng/mL) | %CV | Conc. (ng/mL) | %CV | Conc. (ng/mL) | %CV |
| NC | 0 | 15.8 | 0 | 4.9 | 0 | 5.2 | 0 | 3.6 | 0 | 9.2 |
| HPC | 1600 | 14.2 | 5000 | 9.9 | 10000 | 9.5 | 10000 | 8.8 | 10000 | 19.2 |
| LPC | 3 | 12.4 | 50 | 13.2 | 250 | 13.3 | 100 | 10.3 | 100 | 16.1 |
The inter-assay precision (%CV) of NCs and PCs was calculated from at least four method development runs which were performed on different days. Conc.= Concentration; CV = coefficient of variation; NC = Negative control; PC = Positive control; HPC = high positive control; LPC = Low positive control.